« Return to archives | Awards & Advancement

Aethlon Medical establishes advisory board

Monday, January 23, 2012 12:31 PM

Aethlon Medical, a developer of selective therapeutic filtration devices to address life-threatening conditions, has established an Extracorporeal Therapy Scientific advisory board to guide the advancement of the Aethlon Hemopurifier and other therapies developed from the Aethlon Adapt system. 

Initial members of the Aethlon Extracorporeal Therapy Scientific advisory board include John Kellum, M.D., whose research spans aspects of critical care nephrology, sepsis and multi-organ failure; Gregory T. A. Kovacs, M.D., Ph.D., who has led and co-led studies on topics from chemical and biological instrumentation to jungle warfare technologies; Nathan Levin, M.D., who has lectured internationally on topics relating to chronic kidney disease and hemodialysis; Hans Dietrich Polaschegg, Ph.D., an internationally respected scientist and authority on medical devices for renal care; Claudio Ronco, M.D., editor in chief of the International Journal of Artificial Organs and established author in the nephrology field; and David Ward, M.D, who is trained in nephrology and renal immunopathology.

Share:          
CWWeekly

February 21

Survey: Sponsors, CROs making changes to their business models to demonstrate value to payers

Cegedim ranks top pharma companies on their use of, and success with, social media

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

February

Anticipating the rise of virtual drug development
With the rising cost of drug development and a continued shortage of new products entering the marketplace, the virtual pharma model is expected to become more prevalent going forward, particularly as pharma companies have...

Closing investigative site operations a complex process
In light of the shrinking investigative site landscape, CenterWatch has conducted in-depth case studies of sites closing their operations. Site personnel offer insights into...

Eye On Shire
Shire is a rapidly growing, global specialty biopharmaceutical company, directly marketing its products in over 50 countries...

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2012 CenterWatch.